| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |